Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates

Autor: Pittman, Phillip R., Norris, Sarah L., Brown, Elizabeth S., Ranadive, Manmohan V., Schibly, Barbara A., Bettinger, George E., Lokugamage, Nandadeva, Korman, Lawrence, Morrill, John C., Peters, Clarence J.
Zdroj: In Vaccine 20 January 2016 34(4):523-530
Databáze: ScienceDirect
Externí odkaz: